ATE156121T1 - Histamin-h3-rezeptor-agonisten zur therapeutischen anwendung, pharmazeutische zubereitungen, die an h3-rezeptoren-agonistisch wirken, un die methode ihrer darstellung - Google Patents

Histamin-h3-rezeptor-agonisten zur therapeutischen anwendung, pharmazeutische zubereitungen, die an h3-rezeptoren-agonistisch wirken, un die methode ihrer darstellung

Info

Publication number: ATE156121T1
Authority: AT; Austria
Prior art keywords: histamine; pct; compounds; receptor agonists; receptor
Prior art date: 1990-05-09

Application number

AT91910312T

Other languages

English (en)

Inventor

Monique Garbarg

Jean-Michel Arrang

Walter Schunack

Ralph Lipp

Holger Stark

Jeanne-Marie Lecomte

Jean-Charles Schwartz

Original Assignee

Inst Nat Sante Rech Med

Bioprojet Soc Civ

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-05-09

Filing date

1991-05-10

Publication date

1997-08-15

1991-05-10 Application filed by Inst Nat Sante Rech Med, Bioprojet Soc Civ filed Critical Inst Nat Sante Rech Med

1997-08-15 Application granted granted Critical

1997-08-15 Publication of ATE156121T1 publication Critical patent/ATE156121T1/de

Links

238000002360 preparation method Methods 0.000 title abstract 2
230000001225 therapeutic effect Effects 0.000 title abstract 2
239000003382 histamine H3 receptor agonist Substances 0.000 title 1
238000000034 method Methods 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
239000000018 receptor agonist Substances 0.000 title 1
229940044601 receptor agonist Drugs 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 4
NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 abstract 2
102000004384 Histamine H3 receptors Human genes 0.000 abstract 2
108090000981 Histamine H3 receptors Proteins 0.000 abstract 2
239000000556 agonist Substances 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
150000001412 amines Chemical class 0.000 abstract 1
230000003266 anti-allergic effect Effects 0.000 abstract 1
230000001773 anti-convulsant effect Effects 0.000 abstract 1
230000001430 anti-depressive effect Effects 0.000 abstract 1
230000003110 anti-inflammatory effect Effects 0.000 abstract 1
230000001262 anti-secretory effect Effects 0.000 abstract 1
230000000767 anti-ulcer Effects 0.000 abstract 1
239000001961 anticonvulsive agent Substances 0.000 abstract 1
239000000935 antidepressant agent Substances 0.000 abstract 1
229940005513 antidepressants Drugs 0.000 abstract 1
229960003965 antiepileptics Drugs 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
229960001340 histamine Drugs 0.000 abstract 1
229940126601 medicinal product Drugs 0.000 abstract 1
230000007935 neutral effect Effects 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
150000003141 primary amines Chemical group 0.000 abstract 1
102000005962 receptors Human genes 0.000 abstract 1
108020003175 receptors Proteins 0.000 abstract 1
239000000932 sedative agent Substances 0.000 abstract 1
230000001624 sedative effect Effects 0.000 abstract 1
-1 sleep-regulating Substances 0.000 abstract 1
238000003786 synthesis reaction Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Anesthesiology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

AT91910312T 1990-05-09 1991-05-10 Histamin-h3-rezeptor-agonisten zur therapeutischen anwendung, pharmazeutische zubereitungen, die an h3-rezeptoren-agonistisch wirken, un die methode ihrer darstellung ATE156121T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9005776A FR2661909B1 (fr)	1990-05-09	1990-05-09	Nouveaux composes agonistes du recepteur h3 de l'histamine a usage therapeutique, compositions pharmaceutiques agissant comme agonistes dudit recepteur et procede de preparation.

Publications (1)

Publication Number	Publication Date
ATE156121T1 true ATE156121T1 (de)	1997-08-15

Family

ID=9396429

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91910312T ATE156121T1 (de)	1990-05-09	1991-05-10	Histamin-h3-rezeptor-agonisten zur therapeutischen anwendung, pharmazeutische zubereitungen, die an h3-rezeptoren-agonistisch wirken, un die methode ihrer darstellung

Country Status (11)

Country	Link
US (1)	US5342960A (de)
EP (1)	EP0482183B1 (de)
JP (1)	JP3094384B2 (de)
AT (1)	ATE156121T1 (de)
CA (1)	CA2063550C (de)
DE (1)	DE69127045T2 (de)
DK (1)	DK0482183T3 (de)
ES (1)	ES2107464T3 (de)
FR (1)	FR2661909B1 (de)
GR (1)	GR3024991T3 (de)
WO (1)	WO1991017146A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69205287T2 (de) *	1991-12-18	1996-03-14	Schering Corp., Kenilworth, N.J.	Imidazolylalkyl- piperazin und -diazepin derivate als histamin h3 agonisten/antagonisten.
US5633250A (en) *	1991-12-18	1997-05-27	Schering Corporation	Imidazoylalkyl substituted with a six or seven membered heterocyclic ring containing two nitrogen atoms
WO1993020061A1 (en) *	1992-04-01	1993-10-14	The University Of Toledo	4-[4'-piperidinyl or 3'-pirrolidinyl] substituted imidazoles as h3-receptor antagonists and therapeutic uses thereof
US5486526A (en) *	1992-04-01	1996-01-23	The University Of Toledo	Histamine H3 -receptor antagonists and therapeutic uses thereof
US5639775A (en) *	1992-04-01	1997-06-17	The University Of Toledo	4-[4'-piperodinyl or 3'-pirrolidinyl] substituted imidazoles as H3 -receptor antagonists and therapeutic uses thereof
US6407132B1 (en)	1997-07-25	2002-06-18	James Black Foundation Limited	Substituted imidazole derivatives and their use as histamine H3 receptor ligands
GB9803536D0 (en) *	1998-02-19	1998-04-15	Black James Foundation	Histamine H,receptor ligands
JP2000189171A (ja) *	1998-12-25	2000-07-11	Banyu Pharmaceut Co Ltd	新規なグアノシン三リン酸（ｇｔｐ）結合タンパク質共役型のレセプタ―タンパク質
WO2000042023A1 (en)	1999-01-18	2000-07-20	Novo Nordisk A/S	Substituted imidazoles, their preparation and use
US6908926B1 (en)	1999-04-16	2005-06-21	Novo Nordisk A/S	Substituted imidazoles, their preparation and use
US6437147B1 (en)	2000-03-17	2002-08-20	Novo Nordisk	Imidazole compounds
US6610721B2 (en)	2000-03-17	2003-08-26	Novo Nordisk A/S	Imidazo heterocyclic compounds
AU2003227358A1 (en) *	2002-04-24	2003-11-10	Banyu Pharmaceutical Co., Ltd.	Histamine receptor h3 ordinary activity mutant and utilization thereof
EA200701852A1 (ru)	2005-04-28	2008-04-28	Пфайзер Лимитед	Производные аминокислот

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT71651B (en) *	1979-08-15	1982-01-21	Merck & Co Inc	Process for preparing allysulfoxide enzyme inhibitors
FR2548183B1 (fr) *	1983-07-01	1985-10-31	Synthelabo	Diphenylazomethines portant un radical imidazolyle, leur preparation et leur application en therapeutique
NL8501093A (nl) *	1985-04-12	1986-11-03	Stamicarbon	Werkwijze voor het racemiseren van een optisch aktief n- benzylideenaminozuuramide.
FR2586562B1 (fr) *	1985-09-02	1989-03-10	Inst Nat Sante Rech Med	Composition pharmaceutique contenant de l'a-methylhistamine
FR2630328B1 (fr) *	1988-04-22	1990-08-24	Inst Nat Sante Rech Med	Derive de l'histamine, sa preparation et son application en therapeutique

1990
- 1990-05-09 FR FR9005776A patent/FR2661909B1/fr not_active Expired - Fee Related
1991
- 1991-05-10 EP EP91910312A patent/EP0482183B1/de not_active Expired - Lifetime
- 1991-05-10 WO PCT/FR1991/000384 patent/WO1991017146A1/fr not_active Ceased
- 1991-05-10 ES ES91910312T patent/ES2107464T3/es not_active Expired - Lifetime
- 1991-05-10 JP JP03509563A patent/JP3094384B2/ja not_active Expired - Lifetime
- 1991-05-10 DE DE69127045T patent/DE69127045T2/de not_active Expired - Lifetime
- 1991-05-10 DK DK91910312.7T patent/DK0482183T3/da active
- 1991-05-10 US US07/828,936 patent/US5342960A/en not_active Expired - Lifetime
- 1991-05-10 CA CA002063550A patent/CA2063550C/en not_active Expired - Lifetime
- 1991-05-10 AT AT91910312T patent/ATE156121T1/de not_active IP Right Cessation
1997
- 1997-10-09 GR GR970402634T patent/GR3024991T3/el unknown

Also Published As

Publication number	Publication date
GR3024991T3 (en)	1998-01-30
FR2661909A1 (fr)	1991-11-15
EP0482183A1 (de)	1992-04-29
JPH06501241A (ja)	1994-02-10
DK0482183T3 (da)	1998-03-09
DE69127045D1 (de)	1997-09-04
EP0482183B1 (de)	1997-07-30
DE69127045T2 (de)	1998-03-05
US5342960A (en)	1994-08-30
FR2661909B1 (fr)	1997-08-14
CA2063550C (en)	2002-02-26
ES2107464T3 (es)	1997-12-01
CA2063550A1 (en)	1991-11-10
JP3094384B2 (ja)	2000-10-03
WO1991017146A1 (fr)	1991-11-14

Legal Events

Date	Code	Title	Description
1998-03-15	UEP	Publication of translation of european patent specification
2011-08-15	EELA	Cancelled due to lapse of time

Publication	Publication Date	Title
ATE156121T1 (de)	1997-08-15	Histamin-h3-rezeptor-agonisten zur therapeutischen anwendung, pharmazeutische zubereitungen, die an h3-rezeptoren-agonistisch wirken, un die methode ihrer darstellung
NZ297879A (en)	1998-12-23	Ondansetron and polyhydric alcohol (a sweetener) in a liquid acidic oral composition form
MY114698A (en)	2002-12-31	A process for the isolation of galanthamine
AU2614995A (en)	1995-12-18	Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
PL319373A1 (en)	1997-08-04	Method of producing single doses by wet granulation
PL314188A1 (en)	1996-09-02	Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions
DE69532580D1 (de)	2004-03-25	Neue antagonistische verbindungen
GB9424766D0 (en)	1995-02-08	Pharmaceutical composition
DE69433012D1 (de)	2003-09-11	Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
FI932388A0 (fi)	1993-05-26	8-en-19,11b-bryggsteroider, deras framstaellning och farmaceutiska preparat innehaollande dem
DE59607683D1 (de)	2001-10-18	Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
EP0344980A3 (de)	1991-05-15	Alpha-adrenergische Rezeptorantagonisten
MX9806292A (es)	1998-11-30	Formulacion de un inhibidor de la 5alfa-reductasa para su administracion oral, y un procedimiento de preparacion y uso del mismo.
EP0344981A3 (de)	1991-05-15	Alpha-adrenergische Rezeptorantagonisten